RGO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 696.8 EUR 0.66% Market Closed

Market Cap: €76.8B

R	Regeneron Pharmaceuticals Inc F:RGO	US
	Bankinter SA F:BAKA	ES
A	AltaGas Ltd OTC:ATGFF	CA
F	Fresenius Medical Care AG DUS:FME	DE
	Royalty Pharma PLC NASDAQ:RPRX	US
A	AbbVie Inc SWB:4AB	US
C	Continental AG XHAM:CON	DE
C	Chemours Co SWB:2CU	US
M	MGIC Investment Corp XMUN:MGC	US
P	Perusahaan Gas Negara Tbk PT SWB:PGB1	ID
A	Air Products and Chemicals Inc SWB:AP3	US
G	General Dynamics Corp DUS:GDX	US
	Scentre Group ASX:SCG	AU
	Mobilezone Holding AG F:TGE1	CH
	Holcim AG F:HLB	CH

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Healthy Operating Margin

28%

Sustainable 3Y Average Operating Margin

30%

Declining Operating Margin

36% > 28%

Healthy Net Margin

28%

Strong 3Y Average Net Margin

31%

Declining Net Margin

34% > 28%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

26%

Declining Free Cash Flow Margin

24% > 23%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC

21% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.